Michael Gladstone - Net Worth and Insider Trading
Michael Gladstone Net Worth
The estimated net worth of Michael Gladstone is at least $12 Million dollars as of 2024-05-13. Michael Gladstone is the Director of Day One Biopharmaceuticals Inc and owns about 766,667 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $12 Million. Details can be seen in Michael Gladstone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Gladstone has not made any transactions after 2022-06-17 and currently still holds the listed stock(s).
Transaction Summary of Michael Gladstone
Michael Gladstone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Gladstone owns 2 companies in total, including Day One Biopharmaceuticals Inc (DAWN) , and Third Harmonic Bio Inc (THRD) .
Click here to see the complete history of Michael Gladstone’s form 4 insider trades.
Insider Ownership Summary of Michael Gladstone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2022-06-17 | director |
| THRD | Third Harmonic Bio Inc | 2022-09-14 | director |
Michael Gladstone Latest Holdings Summary
Michael Gladstone currently owns a total of 1 stock. Michael Gladstone owns 766,667 shares of Day One Biopharmaceuticals Inc (DAWN) as of June 17, 2022, with a value of $12 Million.
Latest Holdings of Michael Gladstone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2022-06-17 | 766,667 | 16.05 | 12,305,005 |
Holding Weightings of Michael Gladstone
Michael Gladstone Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Gladstone has made a total of 1 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the acquisition of 766,667 shares on June 17, 2022, which cost Michael Gladstone around $12 Million.
Insider Trading History of Michael Gladstone
- 1
Michael Gladstone Trading Performance
GuruFocus tracks the stock performance after each of Michael Gladstone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Gladstone is 36.42%. GuruFocus also compares Michael Gladstone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Gladstone within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Gladstone's insider trading performs compared to the benchmark.
Performance of Michael Gladstone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.22 | | | | | |
| Relative Return to S&P 500(%) | 16.1 | | | | | |
Michael Gladstone Ownership Network
Michael Gladstone Owned Company Details
What does Day One Biopharmaceuticals Inc do?
Who are the key executives at Day One Biopharmaceuticals Inc?
Michael Gladstone is the director of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include COO & CFO and Secretary York Charles N Ii , director & Chief Executive Officer Jeremy Bender , and Chief Medical Officer Samuel C. Blackman .
Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary
Over the past 18 months, Michael Gladstone made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 116,607 shares made by Samuel C. Blackman , a net sale of 150,568 shares made by Jeremy Bender , and a net sale of 106,697 shares made by York Charles N Ii .
In summary, during the past 3 months, insiders sold 225,453 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 225,453 shares. During the past 18 months, 471,785 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,772,899 shares.
Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Day One Biopharmaceuticals Inc Insider Transactions
Michael Gladstone Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Gladstone. You might contact Michael Gladstone via mailing address: 395 Oyster Point Blvd, Suite 217, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
